ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability
Authors:
- 23 January 2018
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 67 (4) , 769-781
Abstract
Tight junctions (TJs) involve close apposition of transmembrane proteins between cells. Although TJ proteins have been studied in detail, the role of lipids is largely unknown. We addressed the role of very long-chain (VLC ≥26) ceramides in TJs using diabetes-induced loss of the blood-retinal barrier as a model. VLC fatty acids that incorporate into VLC ceramides are produced by elongase elongation of very long-chain fatty acids protein 4 (ELOVL4). ELOVL4 is significantly reduced in the diabetic retina. Overexpression of ELOVL4 significantly decreased basal permeability, inhibited vascular endothelial growth factor (VEGF)– and interleukin-1β–induced permeability, and prevented VEGF-induced decrease in occludin expression and border staining of TJ proteins ZO-1 and claudin-5. Intravitreal delivery of AAV2-hELOVL4 reduced diabetes-induced increase in vascular permeability. Ultrastructure and lipidomic analysis revealed that ω-linked acyl-VLC ceramides colocalize with TJ complexes. Overall, normalization of retinal ELOVL4 expression could prevent blood-retinal barrier dysregulation in diabetic retinopathy through an increase in VLC ceramides and stabilization of TJs.Keywords
Funding Information
- JDRF (3-PDF-2014-108-A-N)
- National Eye Institute (EY-016077, EY-025383, EY-012021)
- NIH (P30-EY007003)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK020572)
- AgBioResearch (MICL02163)
This publication has 55 references indexed in Scilit:
- Interleukin receptor activates a MYD88–ARNO–ARF6 cascade to disrupt vascular stabilityNature, 2012
- Essential Role of ELOVL4 Protein in Very Long Chain Fatty Acid Synthesis and Retinal FunctionJournal of Biological Chemistry, 2012
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Effects of Medical Therapies on Retinopathy Progression in Type 2 DiabetesNew England Journal of Medicine, 2010
- Inhibition of Cytokine Signaling in Human Retinal Endothelial Cells through Downregulation of Sphingomyelinases by Docosahexaenoic AcidInvestigative Ophthalmology & Visual Science, 2010
- Global Analysis of Retina Lipids by Complementary Precursor Ion and Neutral Loss Mode Tandem Mass Spectrometry2009
- Occludin Phosphorylation and Ubiquitination Regulate Tight Junction Trafficking and Vascular Endothelial Growth Factor-induced PermeabilityJournal of Biological Chemistry, 2009
- Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acidsProceedings of the National Academy of Sciences, 2008
- A Stargardt disease‐3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32–C36 acyl phosphatidylcholinesFEBS Letters, 2007
- Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique ω-O-acylceramides in skin leading to neonatal deathHuman Molecular Genetics, 2007